ScholarIQanswers from OpenAlex

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

PaperCitations, authors & open-access status

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma have?

ScholarIQcitation count

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma has 226 citations in the OpenAlex counts ScholarIQ stores.

When was Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma published?

ScholarIQyear

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma has 2008 year in the ScholarIQ index.

What is the open-access status of Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma?

ScholarIQoa status

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma has closed oa status in the ScholarIQ index.

What is the DOI of Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma?

ScholarIQdoi

The DOI for Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma is on the source record.

What is the PMID of Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma?

ScholarIQpmid

The PMID for Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma is on the source record.

What is the OpenAlex record for Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma?

ScholarIQopenalex

The OpenAlex for Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial